245 related articles for article (PubMed ID: 26494789)
21. A Small-Molecule Inhibitor of Bax and Bak Oligomerization Prevents Genotoxic Cell Death and Promotes Neuroprotection.
Niu X; Brahmbhatt H; Mergenthaler P; Zhang Z; Sang J; Daude M; Ehlert FGR; Diederich WE; Wong E; Zhu W; Pogmore J; Nandy JP; Satyanarayana M; Jimmidi RK; Arya P; Leber B; Lin J; Culmsee C; Yi J; Andrews DW
Cell Chem Biol; 2017 Apr; 24(4):493-506.e5. PubMed ID: 28392146
[TBL] [Abstract][Full Text] [Related]
22. A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cells.
Subas Satish HP; Iyer S; Shi MX; Wong AW; Fischer KC; Wardak AZ; Lio D; Brouwer JM; Uren RT; Czabotar PE; Miller MS; Kluck RM
Cell Death Differ; 2024 Jun; 31(6):711-721. PubMed ID: 38582955
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.
Konopleva M; Contractor R; Tsao T; Samudio I; Ruvolo PP; Kitada S; Deng X; Zhai D; Shi YX; Sneed T; Verhaegen M; Soengas M; Ruvolo VR; McQueen T; Schober WD; Watt JC; Jiffar T; Ling X; Marini FC; Harris D; Dietrich M; Estrov Z; McCubrey J; May WS; Reed JC; Andreeff M
Cancer Cell; 2006 Nov; 10(5):375-88. PubMed ID: 17097560
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of anti-leukemic activity of the Bcl-2 homology domain-3 mimetic S1.
Liu Y; Li Z; Song T; Xue Z; Zhang Z
Biomed Pharmacother; 2013 Sep; 67(7):583-91. PubMed ID: 23706691
[TBL] [Abstract][Full Text] [Related]
25. Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak.
Sun JG; Xiang J; Zeng XL; Li X; Wu P; Fung KP; Liu FY
Cancer Lett; 2014 Dec; 355(2):253-63. PubMed ID: 25304383
[TBL] [Abstract][Full Text] [Related]
26. Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak.
Castilla C; Congregado B; Chinchón D; Torrubia FJ; Japón MA; Sáez C
Endocrinology; 2006 Oct; 147(10):4960-7. PubMed ID: 16794010
[TBL] [Abstract][Full Text] [Related]
27. MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor.
Xiao Y; Nimmer P; Sheppard GS; Bruncko M; Hessler P; Lu X; Roberts-Rapp L; Pappano WN; Elmore SW; Souers AJ; Leverson JD; Phillips DC
Mol Cancer Ther; 2015 Aug; 14(8):1837-47. PubMed ID: 26013319
[TBL] [Abstract][Full Text] [Related]
28. Activation of the mitochondrial death pathway is commonly mediated by a preferential engagement of Bak.
Neise D; Graupner V; Gillissen BF; Daniel PT; Schulze-Osthoff K; Jänicke RU; Essmann F
Oncogene; 2008 Feb; 27(10):1387-96. PubMed ID: 17724463
[TBL] [Abstract][Full Text] [Related]
29. Importance of Bak for celecoxib-induced apoptosis.
Müller AC; Handrick R; Elsaesser SJ; Rudner J; Henke G; Ganswindt U; Belka C; Jendrossek V
Biochem Pharmacol; 2008 Oct; 76(9):1082-96. PubMed ID: 18778687
[TBL] [Abstract][Full Text] [Related]
30. AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death.
Jia J; Ji W; Saliba AN; Csizmar CM; Ye K; Hu L; Peterson KL; Schneider PA; Meng XW; Venkatachalam A; Patnaik MM; Webster JA; Smith BD; Ghiaur G; Wu X; Zhong J; Pandey A; Flatten KS; Deng Q; Wang H; Kaufmann SH; Dai H
Cell Death Differ; 2024 Apr; 31(4):405-416. PubMed ID: 38538744
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial E3 ubiquitin ligase MARCHF5 controls BAK apoptotic activity independently of BH3-only proteins.
Huang AS; Chin HS; Reljic B; Djajawi TM; Tan IKL; Gong JN; Stroud DA; Huang DCS; van Delft MF; Dewson G
Cell Death Differ; 2023 Mar; 30(3):632-646. PubMed ID: 36171332
[TBL] [Abstract][Full Text] [Related]
32. A high-throughput image-based screen for the identification of Bax/Bak-independent caspase activators against drug-resistant cancer cells.
Seervi M; Sobhan PK; Mathew KA; Joseph J; Pillai PR; Santhoshkumar TR
Apoptosis; 2014 Jan; 19(1):269-84. PubMed ID: 24220853
[TBL] [Abstract][Full Text] [Related]
33. Minimalist Model Systems Reveal Similarities and Differences between Membrane Interaction Modes of MCL1 and BAK.
Landeta O; Landajuela A; Garcia-Saez A; Basañez G
J Biol Chem; 2015 Jul; 290(27):17004-19. PubMed ID: 25987560
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXA.
Subramanian A; Andronache A; Li YC; Wade M
Oncotarget; 2016 Mar; 7(13):15986-6002. PubMed ID: 26910119
[TBL] [Abstract][Full Text] [Related]
35. High-resolution analysis of the conformational transition of pro-apoptotic Bak at the lipid membrane.
Sperl LE; Rührnößl F; Schiller A; Haslbeck M; Hagn F
EMBO J; 2021 Oct; 40(20):e107159. PubMed ID: 34523144
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer.
Ye Z; Hao R; Cai Y; Wang X; Huang G
Tumour Biol; 2016 Apr; 37(4):4509-15. PubMed ID: 26503209
[TBL] [Abstract][Full Text] [Related]
37. Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477.
Mallick DJ; Soderquist RS; Bates D; Eastman A
Cell Death Dis; 2019 Feb; 10(3):185. PubMed ID: 30796196
[TBL] [Abstract][Full Text] [Related]
38. Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells.
Zhou C; Pan W; Wang XP; Chen TS
J Cell Physiol; 2012 Dec; 227(12):3778-86. PubMed ID: 22378505
[TBL] [Abstract][Full Text] [Related]
39. Physiological restraint of Bak by Bcl-xL is essential for cell survival.
Lee EF; Grabow S; Chappaz S; Dewson G; Hockings C; Kluck RM; Debrincat MA; Gray DH; Witkowski MT; Evangelista M; Pettikiriarachchi A; Bouillet P; Lane RM; Czabotar PE; Colman PM; Smith BJ; Kile BT; Fairlie WD
Genes Dev; 2016 May; 30(10):1240-50. PubMed ID: 27198225
[TBL] [Abstract][Full Text] [Related]
40. Characterization of an alternative BAK-binding site for BH3 peptides.
Ye K; Meng WX; Sun H; Wu B; Chen M; Pang YP; Gao J; Wang H; Wang J; Kaufmann SH; Dai H
Nat Commun; 2020 Jul; 11(1):3301. PubMed ID: 32620849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
